Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bayer HealthCare Aktiengesellschaft
Woman and Man Max 99 years
Bayer HealthCare Aktiengesellschaft
Update Il y a 5 ans
Study of the efficacy, safety and tolerability of repeated administration of eye drops containing regorafenib in newly diagnosed patients with "wet" or neovascular ("new blood vessel growth") Age-Related Macular Degeneration (wet AMD). Kombinovaná studie fáze IIa/IIb účinnosti, bezpečnosti a snášenlivosti opakovaných dávek očních kapek regorafenibu u dosud neléčených subjektů s věkem podmíněnou neovaskulární makulární degenerací
Assess the effect of treatment with regorafenib eye drops on visual acuity at Study Week 4 and at Study Week 12 in subjects with subfoveal choroidal neovascularization due to age related macular degen...
Country
None
organs
None
Specialty
None
Closed trial
More information